These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 24251882)

  • 1. Modelling the time course of antimalarial parasite killing: a tour of animal and human models, translation and challenges.
    Patel K; Simpson JA; Batty KT; Zaloumis S; Kirkpatrick CM
    Br J Clin Pharmacol; 2015 Jan; 79(1):97-107. PubMed ID: 24251882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Semi-mechanistic pharmacokinetic/pharmacodynamic modelling of the antimalarial effect of artemisinin.
    Gordi T; Xie R; Jusko WJ
    Br J Clin Pharmacol; 2005 Dec; 60(6):594-604. PubMed ID: 16305583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Split dosing of artemisinins does not improve antimalarial therapeutic efficacy.
    White NJ; Watson J; Ashley EA
    Sci Rep; 2017 Sep; 7(1):12132. PubMed ID: 28935919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Dynamic Stress Model Explains the Delayed Drug Effect in Artemisinin Treatment of Plasmodium falciparum.
    Cao P; Klonis N; Zaloumis S; Dogovski C; Xie SC; Saralamba S; White LJ; Fowkes FJI; Tilley L; Simpson JA; McCaw JM
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993326
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Zaloumis SG; Cao P; Dini S; Davenport MP; Cromer D; Khoury DS; Fowkes FJI; McCaw JM; Simpson JA
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30249691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of Ivermectin and Its Metabolites against Asexual Blood Stage Plasmodium falciparum and Its Interactions with Antimalarial Drugs.
    Yipsirimetee A; Tipthara P; Hanboonkunupakarn B; Tripura R; Lek D; Kümpornsin K; Lee MCS; Sattabongkot J; Dondorp AM; White NJ; Kobylinski KC; Tarning J; Chotivanich K
    Antimicrob Agents Chemother; 2023 Jul; 67(7):e0173022. PubMed ID: 37338381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local emergence in Amazonia of
    Mathieu LC; Cox H; Early AM; Mok S; Lazrek Y; Paquet JC; Ade MP; Lucchi NW; Grant Q; Udhayakumar V; Alexandre JS; Demar M; Ringwald P; Neafsey DE; Fidock DA; Musset L
    Elife; 2020 May; 9():. PubMed ID: 32394893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the utility of an anti-malarial pharmacokinetic-pharmacodynamic model for aiding drug clinical development.
    Zaloumis S; Humberstone A; Charman SA; Price RN; Moehrle J; Gamo-Benito J; McCaw J; Jamsen KM; Smith K; Simpson JA
    Malar J; 2012 Aug; 11():303. PubMed ID: 22931058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetic and pharmacodynamic modelling of artemisinin and mefloquine enantiomers in patients with falciparum malaria.
    Svensson US; Alin H; Karlsson MO; Bergqvist Y; Ashton M
    Eur J Clin Pharmacol; 2002 Aug; 58(5):339-51. PubMed ID: 12185558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artemisinin resistance in Plasmodium falciparum: what is it really?
    Ferreira PE; Culleton R; Gil JP; Meshnick SR
    Trends Parasitol; 2013 Jul; 29(7):318-20. PubMed ID: 23768531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combined antimalarial therapy using artemisinin].
    Majori G
    Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
    Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
    Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How genomics is contributing to the fight against artemisinin-resistant malaria parasites.
    Cravo P; Napolitano H; Culleton R
    Acta Trop; 2015 Aug; 148():1-7. PubMed ID: 25910626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of quantitative pharmacology tools to improve malaria treatments.
    Davis TM; Moore BR; Salman S; Page-Sharp M; Batty KT; Manning L
    Expert Rev Clin Pharmacol; 2016; 9(2):303-16. PubMed ID: 26652110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altering Antimalarial Drug Regimens May Dramatically Enhance and Restore Drug Effectiveness.
    Kay K; Hodel EM; Hastings IM
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6419-27. PubMed ID: 26239993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Qinghaosu (artemisinin): the price of success.
    White NJ
    Science; 2008 Apr; 320(5874):330-4. PubMed ID: 18420924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mathematical modelling of the chemotherapy of Plasmodium falciparum malaria with artesunate: postulation of 'dormancy', a partial cytostatic effect of the drug, and its implication for treatment regimens.
    Hoshen MB; Na-Bangchang K; Stein WD; Ginsburg H
    Parasitology; 2000 Sep; 121 ( Pt 3)():237-46. PubMed ID: 11085244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naturally Acquired Kelch13 Mutations in Plasmodium falciparum Strains Modulate
    Duffy S; Avery VM
    Microbiol Spectr; 2022 Oct; 10(5):e0128221. PubMed ID: 36094220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass campaigns with antimalarial drugs: a modelling comparison of artemether-lumefantrine and DHA-piperaquine with and without primaquine as tools for malaria control and elimination.
    Gerardin J; Eckhoff P; Wenger EA
    BMC Infect Dis; 2015 Mar; 15():144. PubMed ID: 25887935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.